These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16472142)

  • 21. Antidepressant effects of different schedules of repetitive transcranial magnetic stimulation vs. clomipramine in patients with major depression: relationship to changes in cortical excitability.
    Chistyakov AV; Kaplan B; Rubichek O; Kreinin I; Koren D; Feinsod M; Klein E
    Int J Neuropsychopharmacol; 2005 Jun; 8(2):223-33. PubMed ID: 15569397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developments in the field of antidepressants, where do we go now?
    Artigas F
    Eur Neuropsychopharmacol; 2015 May; 25(5):657-70. PubMed ID: 23706576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroactive steroids in depression and anxiety disorders: clinical studies.
    Eser D; Schüle C; Baghai TC; Romeo E; Rupprecht R
    Neuroendocrinology; 2006; 84(4):244-54. PubMed ID: 17159334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant depression: synthesis of recent data.
    Demitrack MA; Thase ME
    Psychopharmacol Bull; 2009; 42(2):5-38. PubMed ID: 19629020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pre-treatment anterior cingulate activity as a predictor of antidepressant response to repetitive transcranial magnetic stimulation (rTMS).
    Langguth B; Wiegand R; Kharraz A; Landgrebe M; Marienhagen J; Frick U; Hajak G; Eichhammer P
    Neuro Endocrinol Lett; 2007 Oct; 28(5):633-8. PubMed ID: 17984932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-frequency repetitive transcranial magnetic stimulation accelerates and enhances the clinical response to antidepressants in major depression: a meta-analysis of randomized, double-blind, and sham-controlled trials.
    Berlim MT; Van den Eynde F; Daskalakis ZJ
    J Clin Psychiatry; 2013 Feb; 74(2):e122-9. PubMed ID: 23473357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined VNS-rTMS treatment in a patient with therapy resistant depression.
    Sperling W; Kornhuber J; Wiltfang J; Bleich S
    Pharmacopsychiatry; 2007 Jan; 40(1):39-40. PubMed ID: 17327961
    [No Abstract]   [Full Text] [Related]  

  • 28. Optimized Treatment Strategy for Depressive Disorder.
    Chen P
    Adv Exp Med Biol; 2019; 1180():201-217. PubMed ID: 31784965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of repetitive transcranial magnetic stimulation and vagal nerve stimulation in the treatment of depression.
    Fitzgerald PB; Daskalakis ZJ
    Curr Opin Psychiatry; 2008 Jan; 21(1):25-9. PubMed ID: 18281837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prelimbic Stimulation Ameliorates Depressive-Like Behaviors and Increases Regional BDNF Expression in a Novel Drug-Resistant Animal Model of Depression.
    Moshe H; Gal R; Barnea-Ygael N; Gulevsky T; Alyagon U; Zangen A
    Brain Stimul; 2016; 9(2):243-50. PubMed ID: 26655599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antidepressant Effects of Repetitive Transcranial Magnetic Stimulation from a Perspective of Neural Network Dynamics].
    Nakamura M
    Brain Nerve; 2017 Mar; 69(3):247-256. PubMed ID: 28270634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging treatments for depression.
    Holtzheimer PE; Nemeroff CB
    Expert Opin Pharmacother; 2006 Dec; 7(17):2323-39. PubMed ID: 17109609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sertraline vs. ELectrical Current Therapy for Treating Depression Clinical Trial--SELECT TDCS: design, rationale and objectives.
    Brunoni AR; Valiengo L; Baccaro A; Zanao TA; de Oliveira JF; Vieira GP; Bueno VF; Goulart AC; Boggio PS; Lotufo PA; Bensenor IM; Fregni F
    Contemp Clin Trials; 2011 Jan; 32(1):90-8. PubMed ID: 20854930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel therapeutic strategies in major depression: focus on RNAi and ketamine.
    Bortolozzi A; Celada P; Artigas F
    Curr Pharm Des; 2014; 20(23):3848-60. PubMed ID: 24180396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repetitive transcranial magnetic stimulation: a putative add-on treatment for major depression in elderly patients.
    Mosimann UP; Schmitt W; Greenberg BD; Kosel M; Müri RM; Berkhoff M; Hess CW; Fisch HU; Schlaepfer TE
    Psychiatry Res; 2004 Apr; 126(2):123-33. PubMed ID: 15123391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment-resistant depression: no panacea, many uncertainties. Adverse effects are a major factor in treatment choice.
    Prescrire Int; 2011 May; 20(116):128-33. PubMed ID: 21648180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterizing the ideal antidepressant therapy to achieve remission.
    Ferrier IN
    J Clin Psychiatry; 2001; 62 Suppl 26():10-5. PubMed ID: 11775087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physical treatments for bipolar disorder: a review of electroconvulsive therapy, stereotactic surgery and other brain stimulation techniques.
    Loo C; Katalinic N; Mitchell PB; Greenberg B
    J Affect Disord; 2011 Jul; 132(1-2):1-13. PubMed ID: 20858566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current and emerging somatic treatment strategies in psychotic major depression.
    Dannon PN; Lowengrub K; Gonopolski Y; Kotler M
    Expert Rev Neurother; 2006 Jan; 6(1):73-80. PubMed ID: 16466314
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.